PubMed:9734661
Annnotations
jnlpba-st-training
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 38-104 | cell_line | denotes | EBV-positive and EBV-negative primary effusion lymphoma cell lines |
T2 | 221-240 | cell_line | denotes | lymphoma cell lines |
T3 | 242-250 | cell_line | denotes | CRO-AP/3 |
T4 | 255-263 | cell_line | denotes | CRO-AP/5 |
T5 | 385-388 | cell_line | denotes | PEL |
T6 | 401-411 | cell_line | denotes | cell lines |
T7 | 466-469 | cell_line | denotes | PEL |
T8 | 476-491 | cell_line | denotes | HHV-8+/EBV- PEL |
T9 | 507-535 | cell_line | denotes | CRO-AP/3 and HHV-8+/EBV+ PEL |
T10 | 551-559 | cell_line | denotes | CRO-AP/5 |
T11 | 594-597 | cell_line | denotes | PEL |
T12 | 604-612 | cell_line | denotes | CRO-AP/3 |
T13 | 617-625 | cell_line | denotes | CRO-AP/5 |
T14 | 731-744 | cell_type | denotes | B-cell origin |
T15 | 751-761 | cell_line | denotes | cell lines |
T16 | 795-800 | protein | denotes | c-MYC |
T17 | 802-807 | protein | denotes | BCL-2 |
T18 | 812-815 | protein | denotes | p53 |
T19 | 851-856 | protein | denotes | BCL-6 |
T20 | 912-926 | cell_line | denotes | PEL cell lines |
T21 | 941-944 | cell_line | denotes | PEL |
T22 | 963-990 | cell_line | denotes | post-germinal centre B cell |
T23 | 1045-1053 | cell_line | denotes | CRO-AP/3 |
T24 | 1058-1077 | cell_line | denotes | CRO-AP/5 cell lines |
T25 | 1142-1145 | cell_line | denotes | PEL |
T26 | 1168-1178 | cell_line | denotes | cell lines |
T27 | 1409-1412 | cell_line | denotes | PEL |
pubmed-sentences-benchmark
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
S1 | 0-141 | Sentence | denotes | Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. |
S2 | 142-390 | Sentence | denotes | In this study we report on the establishment and characterization of two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) which carry infection by human herpesvirus type-8 (HHV-8) and have derived from AIDS-related primary effusion lymphoma (PEL). |
S3 | 391-560 | Sentence | denotes | These two cell lines are representative of different virologic subtypes of PEL, i.e. HHV-8+/EBV- PEL in the case of CRO-AP/3 and HHV-8+/EBV+ PEL in the case of CRO-AP/5. |
S4 | 561-745 | Sentence | denotes | Consistent with the diagnosis of PEL, both CRO-AP/3 and CRO-AP/5 expressed indeterminate (i.e. non-B, non-T) phenotypes although immunogenotypic studies documented their B-cell origin. |
S5 | 746-857 | Sentence | denotes | Both cell lines are devoid of genetic lesions of c-MYC, BCL-2 and p53 as well as gross rearrangements of BCL-6. |
S6 | 858-1040 | Sentence | denotes | Detailed histogenetic characterization of these novel PEL cell lines suggests that PEL may derive from a post-germinal centre B cell which has undergone pre-terminal differentiation. |
S7 | 1041-1146 | Sentence | denotes | The CRO-AP/3 and CRO-AP/5 cell lines may provide a valuable model for clarifying the pathogenesis of PEL. |
S8 | 1147-1413 | Sentence | denotes | In particular, these cell lines may help understand the relative contribution of HHV-8 and EBV to PEL growth and development and may facilitate the identification of recurrent cytogenetic abnormalities highlighting putative novel cancer related loci relevant to PEL. |
genia-medco-coref
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
C1 | 116-140 | NP | denotes | human herpesvirus type-8 |
C2 | 211-264 | NP | denotes | two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) |
C3 | 265-270 | NP | denotes | which |
C4 | 290-322 | NP | denotes | human herpesvirus type-8 (HHV-8) |
C5 | 345-389 | NP | denotes | AIDS-related primary effusion lymphoma (PEL) |
C6 | 391-411 | NP | denotes | These two cell lines |
C7 | 466-469 | NP | denotes | PEL |
C8 | 594-597 | NP | denotes | PEL |
C9 | 599-625 | NP | denotes | both CRO-AP/3 and CRO-AP/5 |
C10 | 725-730 | NP | denotes | their |
C11 | 746-761 | NP | denotes | Both cell lines |
C12 | 900-926 | NP | denotes | these novel PEL cell lines |
C13 | 941-944 | NP | denotes | PEL |
C14 | 961-990 | NP | denotes | a post-germinal centre B cell |
C15 | 991-996 | NP | denotes | which |
C16 | 1041-1077 | NP | denotes | The CRO-AP/3 and CRO-AP/5 cell lines |
C17 | 1142-1145 | NP | denotes | PEL |
C18 | 1162-1178 | NP | denotes | these cell lines |
C19 | 1228-1233 | NP | denotes | HHV-8 |
C20 | 1409-1412 | NP | denotes | PEL |
R1 | C3 | C2 | coref-relat | which,two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) |
R2 | C4 | C1 | coref-ident | human herpesvirus type-8 (HHV-8),human herpesvirus type-8 |
R3 | C6 | C2 | coref-ident | These two cell lines,two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) |
R4 | C7 | C5 | coref-ident | PEL,AIDS-related primary effusion lymphoma (PEL) |
R5 | C8 | C7 | coref-ident | PEL,PEL |
R6 | C9 | C6 | coref-ident | both CRO-AP/3 and CRO-AP/5,These two cell lines |
R7 | C10 | C9 | coref-pron | their,both CRO-AP/3 and CRO-AP/5 |
R8 | C11 | C9 | coref-ident | Both cell lines,both CRO-AP/3 and CRO-AP/5 |
R9 | C12 | C11 | coref-ident | these novel PEL cell lines,Both cell lines |
R10 | C13 | C8 | coref-ident | PEL,PEL |
R11 | C15 | C14 | coref-relat | which,a post-germinal centre B cell |
R12 | C16 | C12 | coref-ident | The CRO-AP/3 and CRO-AP/5 cell lines,these novel PEL cell lines |
R13 | C17 | C13 | coref-ident | PEL,PEL |
R14 | C18 | C16 | coref-ident | these cell lines,The CRO-AP/3 and CRO-AP/5 cell lines |
R15 | C19 | C4 | coref-ident | HHV-8,human herpesvirus type-8 (HHV-8) |
R16 | C20 | C17 | coref-ident | PEL,PEL |
GENIAcorpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 116-140 | virus | denotes | human herpesvirus type-8 |
T2 | 221-240 | cell_line | denotes | lymphoma cell lines |
T3 | 242-250 | cell_line | denotes | CRO-AP/3 |
T4 | 255-263 | cell_line | denotes | CRO-AP/5 |
T5 | 290-314 | virus | denotes | human herpesvirus type-8 |
T6 | 316-321 | virus | denotes | HHV-8 |
T7 | 345-383 | other_name | denotes | AIDS-related primary effusion lymphoma |
T8 | 385-388 | cell_line | denotes | PEL |
T9 | 401-411 | cell_line | denotes | cell lines |
T10 | 444-462 | virus | denotes | virologic subtypes |
T11 | 466-469 | cell_line | denotes | PEL |
T12 | 476-481 | virus | denotes | HHV-8 |
T13 | 507-515 | cell_line | denotes | CRO-AP/3 |
T14 | 520-525 | virus | denotes | HHV-8 |
T15 | 551-559 | cell_line | denotes | CRO-AP/5 |
T16 | 594-597 | cell_line | denotes | PEL |
T17 | 604-612 | cell_line | denotes | CRO-AP/3 |
T18 | 617-625 | cell_line | denotes | CRO-AP/5 |
T19 | 690-713 | other_name | denotes | immunogenotypic studies |
T20 | 731-744 | cell_type | denotes | B-cell origin |
T21 | 751-761 | cell_line | denotes | cell lines |
T22 | 795-800 | protein_molecule | denotes | c-MYC |
T23 | 802-807 | protein_molecule | denotes | BCL-2 |
T24 | 812-815 | protein_molecule | denotes | p53 |
T25 | 851-856 | protein_molecule | denotes | BCL-6 |
T26 | 912-926 | cell_line | denotes | PEL cell lines |
T27 | 941-944 | cell_line | denotes | PEL |
T28 | 963-990 | cell_line | denotes | post-germinal centre B cell |
T29 | 1011-1039 | other_name | denotes | pre-terminal differentiation |
T30 | 1045-1053 | cell_line | denotes | CRO-AP/3 |
T31 | 1058-1077 | cell_line | denotes | CRO-AP/5 cell lines |
T32 | 1142-1145 | cell_line | denotes | PEL |
T33 | 1168-1178 | cell_line | denotes | cell lines |
T34 | 1228-1233 | virus | denotes | HHV-8 |
T35 | 1238-1241 | virus | denotes | EBV |
T36 | 1245-1255 | other_name | denotes | PEL growth |
T37 | 1323-1348 | other_name | denotes | cytogenetic abnormalities |
T38 | 1409-1412 | cell_line | denotes | PEL |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-141 | Sentence | denotes | Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. |
TextSentencer_T2 | 142-390 | Sentence | denotes | In this study we report on the establishment and characterization of two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) which carry infection by human herpesvirus type-8 (HHV-8) and have derived from AIDS-related primary effusion lymphoma (PEL). |
TextSentencer_T3 | 391-560 | Sentence | denotes | These two cell lines are representative of different virologic subtypes of PEL, i.e. HHV-8+/EBV- PEL in the case of CRO-AP/3 and HHV-8+/EBV+ PEL in the case of CRO-AP/5. |
TextSentencer_T4 | 561-745 | Sentence | denotes | Consistent with the diagnosis of PEL, both CRO-AP/3 and CRO-AP/5 expressed indeterminate (i.e. non-B, non-T) phenotypes although immunogenotypic studies documented their B-cell origin. |
TextSentencer_T5 | 746-857 | Sentence | denotes | Both cell lines are devoid of genetic lesions of c-MYC, BCL-2 and p53 as well as gross rearrangements of BCL-6. |
TextSentencer_T6 | 858-1040 | Sentence | denotes | Detailed histogenetic characterization of these novel PEL cell lines suggests that PEL may derive from a post-germinal centre B cell which has undergone pre-terminal differentiation. |
TextSentencer_T7 | 1041-1146 | Sentence | denotes | The CRO-AP/3 and CRO-AP/5 cell lines may provide a valuable model for clarifying the pathogenesis of PEL. |
TextSentencer_T8 | 1147-1413 | Sentence | denotes | In particular, these cell lines may help understand the relative contribution of HHV-8 and EBV to PEL growth and development and may facilitate the identification of recurrent cytogenetic abnormalities highlighting putative novel cancer related loci relevant to PEL. |
T1 | 0-141 | Sentence | denotes | Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. |
T2 | 142-390 | Sentence | denotes | In this study we report on the establishment and characterization of two novel lymphoma cell lines (CRO-AP/3 and CRO-AP/5) which carry infection by human herpesvirus type-8 (HHV-8) and have derived from AIDS-related primary effusion lymphoma (PEL). |
T3 | 391-560 | Sentence | denotes | These two cell lines are representative of different virologic subtypes of PEL, i.e. HHV-8+/EBV- PEL in the case of CRO-AP/3 and HHV-8+/EBV+ PEL in the case of CRO-AP/5. |
T4 | 561-745 | Sentence | denotes | Consistent with the diagnosis of PEL, both CRO-AP/3 and CRO-AP/5 expressed indeterminate (i.e. non-B, non-T) phenotypes although immunogenotypic studies documented their B-cell origin. |
T5 | 746-857 | Sentence | denotes | Both cell lines are devoid of genetic lesions of c-MYC, BCL-2 and p53 as well as gross rearrangements of BCL-6. |
T6 | 858-1040 | Sentence | denotes | Detailed histogenetic characterization of these novel PEL cell lines suggests that PEL may derive from a post-germinal centre B cell which has undergone pre-terminal differentiation. |
T7 | 1041-1146 | Sentence | denotes | The CRO-AP/3 and CRO-AP/5 cell lines may provide a valuable model for clarifying the pathogenesis of PEL. |
T8 | 1147-1413 | Sentence | denotes | In particular, these cell lines may help understand the relative contribution of HHV-8 and EBV to PEL growth and development and may facilitate the identification of recurrent cytogenetic abnormalities highlighting putative novel cancer related loci relevant to PEL. |
PubCasesHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
AB1 | 221-229 | HP:0002665 | denotes | lymphoma |
TI1 | 85-93 | HP:0002665 | denotes | lymphoma |
AB2 | 375-383 | HP:0002665 | denotes | lymphoma |
PubCasesORDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TI1 | 68-93 | ORDO:48686 | denotes | primary effusion lymphoma |
AB1 | 358-383 | ORDO:48686 | denotes | primary effusion lymphoma |
AB2 | 385-388 | ORDO:48686 | denotes | PEL |
AB3 | 466-469 | ORDO:48686 | denotes | PEL |
AB4 | 488-491 | ORDO:48686 | denotes | PEL |
AB5 | 532-535 | ORDO:48686 | denotes | PEL |
AB6 | 594-597 | ORDO:48686 | denotes | PEL |
AB7 | 912-915 | ORDO:48686 | denotes | PEL |
AB8 | 941-944 | ORDO:48686 | denotes | PEL |
AB9 | 1142-1145 | ORDO:48686 | denotes | PEL |
AB10 | 1245-1248 | ORDO:48686 | denotes | PEL |
AB11 | 1409-1412 | ORDO:48686 | denotes | PEL |